Opus Genetics, Stock Price on December 23, 2024
| IRD Stock | 1.03 0.05 5.10% |
Below is the normalized historical share price chart for Opus Genetics, extending back to November 30, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Opus Genetics, stands at 1.03, as last reported on the 24th of December, with the highest price reaching 1.05 and the lowest price hitting 0.95 during the day.
If you're considering investing in Opus Stock, it is important to understand the factors that can impact its price. Opus Genetics, maintains Sharpe Ratio (i.e., Efficiency) of -0.0362, which implies the firm had a -0.0362% return per unit of risk over the last 3 months. Opus Genetics, exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Opus Genetics,'s Coefficient Of Variation of (1,822), risk adjusted performance of (0.03), and Variance of 30.72 to confirm the risk estimate we provide.
The current year's Issuance Of Capital Stock is expected to grow to about 12.7 M, whereas Total Stockholder Equity is forecasted to decline to about 28.8 M. . Opus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of May 2005 |
Opus |
Sharpe Ratio = -0.0362
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IRD |
Estimated Market Risk
| 5.62 actual daily | 50 50% of assets are less volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Opus Genetics, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Opus Genetics, by adding Opus Genetics, to a well-diversified portfolio.
Opus Genetics, Main Headline on 23rd of December 2024
Acquisition by Magrath George of 6200 shares of Opus Genetic... by MacroaxisInsider
Filed transaction by Opus Genetics, Officer Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Opus Genetics, Valuation on December 23, 2024
It is possible to determine the worth of Opus Genetics, on a given historical date. On December 23, 2024 Opus was worth 1.03 at the beginning of the trading date compared to the closed value of 1.03. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Opus Genetics, stock. Still, in general, we apply an absolute valuation method to find Opus Genetics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Opus Genetics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Opus Genetics,'s related companies.
| Open | High | Low | Close | Volume | |
| 1.01 | 1.10 | 0.98 | 0.98 | 399,200 | |
12/23/2024 | 1.03 | 1.05 | 0.95 | 1.03 | 152,145 |
| Backtest Opus Genetics, | | | Opus Genetics, History | | | Opus Genetics, Valuation | Previous |
Opus Genetics, Trading Date Momentum on December 23, 2024
| On December 23 2024 Opus Genetics, was traded for 1.03 at the closing time. Highest Opus Genetics,'s price during the trading hours was 1.05 and the lowest price during the day was 0.95 . The net volume was 152.1 K. The overall trading history on the 23rd of December did not cause price change. The trading delta at closing time to current price is 0.00% . |
Opus Genetics, Fundamentals Correlations and Trends
By evaluating Opus Genetics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Opus Genetics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Opus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Opus Genetics, Stock history
Opus Genetics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Opus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Opus Genetics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Opus Genetics, stock prices may prove useful in developing a viable investing in Opus Genetics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 24 M | 20.5 M |
Opus Genetics, Quarterly Net Working Capital |
|
Opus Genetics, Stock Technical Analysis
Opus Genetics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Opus Genetics, Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Opus Genetics, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Opus Genetics, December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Opus Genetics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Opus Genetics, shares will generate the highest return on investment. By undertsting and applying Opus Genetics, stock market strength indicators, traders can identify Opus Genetics, entry and exit signals to maximize returns
Opus Genetics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Opus Genetics,'s price direction in advance. Along with the technical and fundamental analysis of Opus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Opus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.48) | |||
| Treynor Ratio | (0.13) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Opus Stock analysis
When running Opus Genetics,'s price analysis, check to measure Opus Genetics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opus Genetics, is operating at the current time. Most of Opus Genetics,'s value examination focuses on studying past and present price action to predict the probability of Opus Genetics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opus Genetics,'s price. Additionally, you may evaluate how the addition of Opus Genetics, to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |